Evidence method
Level · gp.fundamentals.capex_revenue_ratio
0.04% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
FEED · Dec 31, 2023
ENvue Medical, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001493152-24-013966General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-157.77% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
203.59% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
119.67% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
67.32% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-150.50% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
8.10% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
12.83% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History16 statesHistory building
Sep 30, 20220/7 normalizedLevel 3Dec 31, 20220/7 normalizedLevel 3Mar 31, 20230/7 normalizedLevel 3Jun 30, 20230/7 normalizedLevel 3Sep 30, 20230/8 normalizedLevel 3Dec 31, 20230/8 normalizedLevel 3Mar 31, 20240/8 normalizedLevel 3Jun 30, 20240/8 normalizedLevel 3Sep 30, 20247/8 normalizedLevel 3Dec 31, 20247/8 normalizedLevel 3Mar 31, 20256/8 normalizedLevel 3Jun 30, 20256/7 normalizedLevel 3Sep 30, 20257/7 normalizedLevel 3Dec 31, 20257/7 normalizedLevel 3Mar 31, 20267/7 normalizedLevel 3Jun 30, 20267/7 normalizedLevel 3
Period transition
What moved in the state?
- Previous
- 0.00%
- Current
- 0.04%
- Delta
- 0.04%
- Previous
- -148.91%
- Current
- -157.77%
- Delta
- -8.87%
- Previous
- 372.16%
- Current
- 203.59%
- Delta
- -168.57%
- Previous
- 694.10%
- Current
- 119.67%
- Delta
- -574.44%
- Previous
- 76.20%
- Current
- 67.32%
- Delta
- -8.88%
- Previous
- -146.29%
- Current
- -150.50%
- Delta
- -4.22%
- Previous
- 7.21%
- Current
- 8.10%
- Delta
- 0.90%
- Previous
- 7.86%
- Current
- 12.83%
- Delta
- 4.97%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · FEED Fundamental State →Has State · ENvue Medical, Inc. →Transitioned To · FEED R_AND_D_INTENSITY_INCREASED →Transitioned To · FEED SBC_INTENSITY_INCREASED →Transitioned To · FEED Fundamental State →Transitioned To · FEED CAPEX_INTENSITY_INCREASED →Transitioned To · FEED CASH_GENERATION_DECREASED →Transitioned To · FEED GROWTH_DECREASED →Transitioned To · FEED INVENTORY_PRESSURE_DECREASED →Transitioned To · FEED MARGIN_DECREASED →Transitioned To · FEED PROFITABILITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.